Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Ginkgo Bioworks Holdings ( (DNA) ) is now available.
On September 4, 2025, Ginkgo Bioworks Holdings entered into a Sales Agreement with Allen & Company LLC to potentially sell up to $100 million of its Class A common stock in at-the-market offerings. The proceeds from these sales, if any, are intended for general corporate purposes, including financing operations and technology development. The agreement allows flexibility in selling shares and includes customary rights and termination options for both parties. This move could impact the company’s market positioning by providing additional capital to support its growth and operations in the competitive synthetic biology industry.
The most recent analyst rating on (DNA) stock is a Sell with a $9.00 price target. To see the full list of analyst forecasts on Ginkgo Bioworks Holdings stock, see the DNA Stock Forecast page.
Spark’s Take on DNA Stock
According to Spark, TipRanks’ AI Analyst, DNA is a Neutral.
The overall stock score of 55 reflects a mixed outlook for Ginkgo Bioworks Holdings. The most significant factor is the company’s financial performance, which shows strong gross margins but struggles with profitability and cash flow. The technical analysis indicates a positive trend, while the earnings call highlights cost reductions and strategic growth initiatives. However, the negative valuation metrics and potential risks in biosecurity revenue and leasing challenges temper the overall score.
To see Spark’s full report on DNA stock, click here.
More about Ginkgo Bioworks Holdings
Ginkgo Bioworks Holdings, Inc. operates in the synthetic biology industry, focusing on developing engineered cells and biomanufacturing processes. The company aims to provide innovative solutions in biotechnology and has a market focus on technology development and operations financing.
Average Trading Volume: 1,650,803
Technical Sentiment Signal: Sell
Current Market Cap: $652.4M
For a thorough assessment of DNA stock, go to TipRanks’ Stock Analysis page.